The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
Open accessAbstract
BACKGROUND: Thrombolysis for acute ischemic stroke has remained controversial. The Canadian Alteplase for Stroke Effectiveness Study, a national prospective cohort study, was conducted to assess the effectiveness of alteplase therapy for ischemic stroke in actual practice. METHODS: The study was mandated by the federal government as a condition of licensure of alteplase for the treatment of stroke in Canada. A registry was established to collect data over 2.5 years for stroke patients receiving such treatment from Feb. 17, 1999, through June 30, 2001. All centres capable of administering thrombolysis therapy according to Canadian guidelines were eligible to submit patient data to the registry. Data collection was prospective, and follow-up was completed at 90 days after stroke. Copies of head CT scans obtained at baseline and at 24-48 hours after the start of treatment were submitted to a central panel for review. RESULTS: A total of 1135 patients were enrolled at 60 centres in all major hospitals across Canada. The registry collected data for an estimated 84% of all treated ischemic stroke patients in the country. An excellent clinical outcome was observed in 37% of the patients. Symptomatic intracranial hemorrhage occurred in only 4.6% of the patients (95% confidence interval [CI] 3.4%-6.0%); however, 75% of these patients died in hospital. An additional 1.3% (95% CI 0.7%-2.2%) of patients had hemiorolingual angioedema. CONCLUSIONS: The outcomes of stroke patients undergoing thrombolysis in Canada are commensurate with the results of clinical trials. The rate of symptomatic intracranial hemorrhage was low. Stroke thrombolysis is a safe and effective therapy in actual practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02237-6 · Cited by 2,668
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Benardete, E. A., & Nair, A. K. (2015) · Cerebrovascular Diseases Extra · doi:10.1159/000370060 · Cited by 2,546
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Pexman, J. H. W., Barber, P. A., Hill, M. D., Sevick, R. J., Demchuk, A. M., Hudon, M. E., Hu, W. Y., & Buchan, A. M. (2001) · PubMed Central · Cited by 910
Self-citationEarly stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies
Becker, K. J., Baxter, A. B., Cohen, W. A., Bybee, H. M., Tirschwell, D. L., Newell, D. W., Winn, H. R., & Longstreth, W. T. (2001) · Neurology · doi:10.1212/wnl.56.6.766 · Cited by 553
Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic?
Berger, C., Fiorelli, M., Steiner, T., Schäbitz, W.-R., Bozzao, L., Bluhmki, E., Hacke, W., & von Kummer, R. (2001) · Stroke · doi:10.1161/01.str.32.6.1330 · Cited by 552
Brott, T. G., Haley, E. C., Levy, D. E., Barsan, W., Broderick, J., Sheppard, G. L., Spilker, J., Kongable, G. L., Massey, S., & Reed, R. (1992) · Stroke · doi:10.1161/01.str.23.5.632 · Cited by 545
The European Cooperative Acute Stroke Study (ECASS)
Kaste, M., Fieschi, C., Hacke, W., Lesaffre, E., Verstraete, M., & Fröhlich, J. (1993) · Thrombolytic Therapy in Acute Ischemic Stroke II · doi:10.1007/978-3-642-78061-5_10 · Cited by 487
Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C. (1998) · Stroke · doi:10.1161/01.str.29.1.18 · Cited by 406
Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Haley, E. C., Levy, D. E., Brott, T. G., Sheppard, G. L., Wong, M. C., Kongable, G. L., Torner, J. C., & Marler, J. R. (1992) · Stroke · doi:10.1161/01.str.23.5.641 · Cited by 347
Donnan, G. A. (1996) · JAMA · doi:10.1001/jama.276.12.961 · Cited by 294
Reed, S. D., Cramer, S. C., Blough, D. K., Meyer, K., & Jarvik, J. G. (2001) · Stroke · doi:10.1161/01.str.32.8.1832 · Cited by 255
Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach
Grond, M., Stenzel, C., Schmülling, S., Rudolf, J., Neveling, M., Lechleuthner, A., Schneweis, S., & Heiss, W.-D. (1998) · Stroke · doi:10.1161/01.str.29.8.1544 · Cited by 246
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., del Zoppo, G. J., Yamaguchi, T., & Berge, E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213 · Cited by 237
Grotta, J. C., Burgin, W. S., El-Mitwalli, A., Long, M., Campbell, M., Morgenstern, L. B., Malkoff, M., & Alexandrov, A. V. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2009 · Cited by 233
ATLANTIS Trial: Results for Patients Treated Within 3 Hours of Stroke Onset
Albers, G. W., Clark, W. M., Madden, K. P., & Hamilton, S. A. (2002) · Stroke · doi:10.1161/hs0202.102599 · Cited by 212
THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSION
Sussman, B. J. (1958) · Journal of the American Medical Association · doi:10.1001/jama.1958.02990310011002 · Cited by 209
Treating Acute Stroke Patients With Intravenous tPA: The OSF Stroke Network Experience
Wang, D. Z., Rose, J. A., Honings, D. S., Garwacki, D. J., & Milbrandt, J. C. (2000) · Stroke · doi:10.1161/01.str.31.1.77 · Cited by 207
Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke
Hill, M. D., Lye, T., Moss, H., Barber, P. A., Demchuk, A. M., Newcommon, N. J., Green, T. L., Kenney, C., Cole–Haskayne, A., & Buchan, A. M. (2003) · Neurology · doi:10.1212/01.wnl.0000058840.66596.1a · Cited by 188
Self-citationPredictors of good outcome after intravenous tPA for acute ischemic stroke
Demchuk, A. M., Tanne, D., Hill, M. D., Kasner, S. E., Hanson, S., Grond, M., Levine, S. R., & The Multicentre tPA Stroke Survey Group (2001) · Neurology · doi:10.1212/wnl.57.3.474 · Cited by 188
Self-citationTanne, D., Bates, V. E., Verro, P., Kasner, S. E., Binder, J. R., Patel, S. C., Mansbach, H. H., Daley, S., Schultz, L. R., Karanjia, P. N., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.424 · Cited by 178
Lopez-Yunez, A. M., Bruno, A., Williams, L. S., Yilmaz, E. Y., Zurrú, C., & Biller, J. (2001) · Stroke · doi:10.1161/01.str.32.1.12 · Cited by 151
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease
Stefanadis, C., & TOUTOUZAS, P. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91066-2 · Cited by 143
Effectiveness of t-PA in acute ischemic stroke
Buchan, A. M., Barber, P. A., Newcommon, N. J., Karbalai, H., Demchuk, A. M., Hoyte, K., Klein, G., & Feasby, T. E. (2000) · Neurology · doi:10.1212/wnl.54.3.679 · Cited by 134
Wardlaw, J. M., Sandercock, P. A., & Berge, E. (2003) · Stroke · doi:10.1161/01.str.0000072513.72262.7e · Cited by 123
Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
Hill, M. D., Barber, P. A., Takahashi, J., Demchuk, A. M., Feasby, T. E., & Buchan, A. M. (2000) · Europe PMC (PubMed Central) · Cited by 117
Self-citationKoennecke, H., Nohr, R., Leistner, S., et al. (2001) · Stroke · doi:10.1161/01.str.32.5.1074 · Cited by 106
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Chapman, K. M., Woolfenden, A. R., Graeb, D. A., Johnston, D. C. C., Beckman, J., Schulzer, M., & Teal, P. A. (2000) · Stroke · doi:10.1161/01.str.31.12.2920 · Cited by 68
Trends in Hospital Admission for Stroke in Calgary
Field, T. S., Green, T., Roy, K., Pedersen, J., & Hill, M. D. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003504 · Cited by 29
Self-citation
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Frontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Metadata
- Authors
- Hill, M. D.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2005-05-10
- Volume
- 172
- Issue
- 10
- Pages
- 1307-1312
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2112328442
- Cited by
- 452
- References
- 44
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.